Frequently Asked Patient Questions About Covid
What is monoclonal antibody treatment for COVID-19?
What is the difference between a monoclonal antibody treatment and a vaccine?
Why is monoclonal antibody treatment being recommended for me?
What is the benefit of taking monoclonal antibody treatment?
How is a monoclonal antibody treatment given?
What do I need to do after I receive monoclonal antibody treatment?
What are the possible side effects of a monoclonal antibody treatment?
Should I get monoclonal antibody treatment as soon as possible? Or should I wait to see if my symptoms get worse?
Are monoclonal antibody treatments effective against viral variants?
1. DHHS. Combat COVID. Accessed May 5, 2021. https://combatcovid.hhs.gov/.
2. Taylor PC, et al. Nat Rev Immunol. 2021. doi:10.1038/s41577-021-00542-x. Online ahead of print.
3. Marcotte H et al. Passive immunization. In: Mestecky J et al, eds. Mucosal Immunity. 4th ed. Vol 2. 2015:1403-1434.
4. CDC. COVID-19. Accessed January 27, 2021. https://www.cdc.gov/coronavirus/2019-nCoV/index.html.
5. National Institute of Health . Coronavirus disease 2019 treatment guidelines. Accessed May 7, 2021. https://www.covid19treatmentguidelines.nih.gov/.
6. Weinreich DM et al. N Engl J Med. 2020. doi:10.1056/NEJMoa2035002.
7. Copin R, et al. bioRxiv. 2021. doi: https://doi.org/10.1101/2021.03.10.434834.
What Is Monoclonal Antibody Treatment For Covid
Antibodies are naturally made in our bodies to fight infection. When our immune system meets a new foreign substance in the body, it makes new antibodies that attack the foreign substance. The next time that substance shows up, our immune system can produce the same antibodies to help the body fight it off before it can make a person sick. These types of naturally occurring antibodies provide active immunity. Monoclonal antibodies are laboratory-made proteins designed to mimic the bodys ability to fight off viruses and pathogens.;
Monoclonal antibody treatment for COVID-19 has received emergency use authorization by the Food and Drug Administration as an investigational medicine used for the treatment of COVID-19 patients at high-risk of developing severe illness.
How Can I Get Monoclonal Antibodies
People who have had symptoms for 10 days or less should be referred for treatment by their healthcare providers and directed to available infusion locations. If you do not have a healthcare provider, call the Combat COVID Monoclonal Antibodies Call Center at 1-877-332-6585 to find out who to talk with about your symptoms and treatment.
There is no cost to anyone for the antibodies themselves, but there may be treatment fees. If you do not have insurance, ask the facility if there will be a charge.
You May Like: Are Stomach Pains A Sign Of Covid
Science Behind New Covid
Early Tuesday evening, the first El Pasoan was brought to the convention center to receive a potentially life-saving treatment called bamlanivimab.
Bamlanivimab is a COVID-19 antibody treatment approved for emergency use just two weeks ago.
Bamlanivimab is a monoclonal antibody that attaches to the COVID-19 virus in the body and prevents it from attaching to cells within the body, Dr. Edward Michelson, Chair of the Department of Emergency Medicine at Texas Tech University Health Sciences Center said.;
A wing of the Convention Center’s makeshift hospital is now dedicated entirely to this new outpatient treatment.
There’s a real hope that this will help us take some of the pressure off the hospitals, Dr. Michelson said.
In order to qualify, a person must meet certain criteria including being healthy enough to go home after the treatment, not relying on oxygen, and falling into a high-risk category.
Potential patients will be screened at a variety of clinics and urgent care sites throughout El Paso.
The treatment is free to those participating and Dr. Michelson said the sooner a COVID-19 positive patient is treated the better.
If you think you or someone you know might be eligible, for more information regarding qualifying factors and screening sites.;
Once approved for the treatment, infusions take only an hour.
If we treat 1000 patients, I think we may save somewhere between 40 and 100 hospitalizations, he said. It’s really hard to know.
Infusion Therapy: A New Way Of Treating The Coronavirus
Infusion therapy is another way people with COVID-19 can be treated.;
An ideal candidate would be someone who tested positive for COVID-19 who isn’t hospitalized, 65 and older, a child, and someone with diabetes or immunocompromised.
“It reduces the risk of getting hospitalized with this disease,’ Cameron County Health Authority Dr. James Castillo said
Compared to convalescent plasma, infusion therapy has specific copies of the spikes found on the outside of the coronavirus, which is use to attach itself to the cells in our body.
Dr. Castillo said those spikes grab on to them and make it so the virus can’t keep getting into you.
In the Rio Grande Valley there are two places where you can get this type of therapy :
Casa de Amistad
Antibody Infusion Treatment Shows Promise In Fight Against Covid
BATON ROUGE, La. – Doctors are seeing promising results with an outpatient antibody treatment. They say this treatment is bringing hope in a time when its most needed. With almost all our hospitals completely overwhelmed and understaffed, doctors and nurses are looking for any sign of relief to keep COVID patients from needing to go to the hospital. And so far this treatment appears to be just that.
Its not another vaccine, and its not a cure for the virus either. But it is showing to be a highly effective treatment for those infected with the virus. So far, doctors have used monoclonal antibody infusion on 9,700 patients throughout Louisiana.
The results of this have been excellent. For the 9,700 patients only 28 of those have been admitted to the hospital after getting monoclonal antibodies, said Warner Thomas, President, and CEO of Ochsner Health.
Unlike the vaccine, which works as a protective layer against covid, the antibody infusion helps prevent the virus from replicating. In other words, keeps it from getting worse. Its passive immunotherapy that can prevent hospitalization and death. But it does not take the place of patients requiring a shot after theyve been treated.
When you look at those numbers the 28 out of 9,700 its less than .3% who actually get the infusion that wind up having to be hospitalized so its a very good treatment, said Dr. Robert Hart with Ochsner.
to report a typo.
How Do Monoclonal Antibodies Work
A monoclonal antibody is a laboratory-produced protein that functions like the antibodies made by the immune system in response to infection.
Monoclonal antibody treatment has been for the Ebola virus and respiratory syncytial virus , as well as chronic illnesses such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and more.
Scientists are also developing monoclonal antibodies that target cancer cells.
Scientists sometimes develop monoclonal antibodies by isolating certain immune cells called B cells from a person who has successfully recovered from an infection.
With COVID-19, we looked in people who had a good antibody response to the virus and picked out the very best antibodies that they made, said Robert Carnahan, PhD, associate director of the Vanderbilt Vaccine Center in Tennessee.
Scientists use isolated B cells to recreate monoclonal antibodies in a laboratory. This can be mass produced and given to people through an IV.
A monoclonal antibody targets a specific antigen on a virus or bacteria. So this treatment differs from convalescent plasma, which contains multiple antibodies that target different antigens.
Most of the monoclonal antibodies being developed to treat COVID-19 target the spike protein, which the coronavirus uses to enter the host cells.
Research suggests that certain monoclonal antibodies can reduce the risk of hospitalization and death in people with asymptomatic or mild COVID-19.
The CDC still
You May Like: Why Is Covid So Contagious
What Are The Side Effects
Side effects can range from mild to serious and may include:
- Wheezing or trouble breathing
- Swollen lips, face or throat
- Flu-like symptoms
- Upset stomach
- Itching, swelling, rash or hives
- Dizziness or low blood pressure
- Changes in your heartbeat
Tell your doctor or nurse right away if you have any side effects during or after your infusion. Keep in mind that only a limited number of people have taken bamlanivimab scientists are still learning about its side effects and risks. Serious and unexpected side effects may occur.
Where To Get Monoclonal Antibody Infusion Therapy
- The Pittsboro Therapeutic Infusion Center
- Childrens Specialty Clinic, Raleigh Blue Ridge
- UNC Rex Healthcare, Raleigh, NC
- Caldwell Infusion Center, Lenoir, NC
- UNC Urgent Care at Clayton, Johnston County
- Lenoir Hospital, Kinston, NC
- Nash COVID Infusion Unit, Rocky Mount, NC
- Rockingham COVID Inpatient Unit, Eden, NC
- Wayne Infusion Center, Goldsboro, NC
- Pardee Hospital, Hendersonville, NC
Recommended Reading: Why Not To Get The Covid Vaccine
Who May Be Eligible To Receive Monoclonal Antibody Treatment
Patients with positive COVID-19 results who are 12 years of age or older and who have had mild to moderate symptoms for less than 10 days are eligible to receive the treatment. Patients with any of the following indicators may benefit from the monoclonal antibody infusion:
- Age 65
- Body mass index 25
- Chronic kidney disease
- Immunosuppressive disease or receiving immunosuppressive treatment
- Poorly controlled hypertension
- Cardiovascular disease or Congenital Heart Disease
- Chronic obstructive pulmonary disease or other respiratory diseases
Medicare Payment For Administering Monoclonal Antibody Products To Treat Covid
To ensure immediate access during the COVID-19 PHE, Medicare covers and pays for these infusions;in accordance with Section 3713 of the Coronavirus Aid, Relief, and Economic Security Act . We’ll address potential refinements to payment for administering monoclonal antibody products to treat COVID-19 through future notice-and-comment rulemaking.
Payment for Infusion
On May 6, 2021, CMS updated the Medicare payment rates for the administration of COVID-19 monoclonal antibody products. Effective for services furnished on or after May 6, 2021, the new Medicare payment rate for administering COVID-19 monoclonal antibody products, authorized or approved by the FDA, is approximately $450. This rate applies to all providers and suppliers not paid reasonable cost for furnishing these products. The new rate reflects updated information about the costs involved in administering monoclonal antibody products for different types of providers and suppliers, and the additional resources necessary to ensure providers administer the products safely and appropriately to COVID-19 positive patients. CMS geographically adjusts the rate based on where you furnish the service.
Medicare also pays for treatment to address major complications:
- As needed and appropriate
- Consistent with existing payment methodologies for the care setting where you provide the treatment
For COVID-19 monoclonal antibody products administered before May 6, 2021, the Medicare payment rate is approximately $310.
Don’t Miss: When Was Covid 19 Declared A Pandemic
Coding For Monoclonal Antibody Products To Treat Covid
CMS identified specific code for each monoclonal antibody product to treat COVID-19 and specific administration code for Medicare payment:;
Long descriptor: Injection, tocilizumab, for hospitalized adults and pediatric patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mg
Short descriptor: Tocilizumab for COVID-19
Long descriptor: Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, includes infusion and post administration monitoring, second dose
Short descriptor: Adm Tocilizu COVID-19 2nd
;1;These rates dont apply if Medicare pays you for preventive vaccines and their administration at reasonable cost .;Also, as indicated in the 2021 Medicare Physician Fee Schedule Final Rule, we continue to seek additional information from the public for further consideration as we review and establish payment rates for vaccine administration services during the PHE and on a longer term basis.
2Given the limited clinical situations allowed under the EUA, you should only bill for tocilizumab on a 12x type of bill .
How Does Monoclonal Antibody Treatment Work
After entering your body, monoclonal antibodies look for and attach to the spike protein that sticks out of the coronavirus that causes COVID-19.
When monoclonal antibodies attach to the spike protein, they can block the virus’s ability to enter cells and slow down the infection.
In 2020, the FDA authorized several different monoclonal antibodies to treat COVID-19. UPMC received two monoclonal antibody infusion treatment products. One of these treatments is sotrovimab, while the other is a combination of the drugs casirivimab and imdevimab.
Recommended Reading: Does Covid Live On Surface
How Is It Different From A Vaccine
A vaccine helps stimulate and prepare your immune system to respond if or when you are exposed to the virus, Petty says. Your immune system is ready to create all these antibodies before they are needed.
Monoclonal antibodies boost the immune system after you are already sick, speeding up your immune response to prevent COVID-19 from getting worse. But a vaccine does this much easier and much better, Petty says.
You can think of monoclonal antibodies as guided missiles that target and neutralize the virus, Fales says. But they don’t stick around. While monoclonal antibodies are effective for about a month, they are long gone 6 months later, when a vaccine still offers significant protection.
What Treatments Can Be Used For Covid
Doctors have developed effective treatments for hospitalized patients.
- Dexamethasone is a corticosteroid . In patients who need extra oxygen or are on a ventilator, dexamethasone can reduce risk of death.
- Remdesivir is an antiviral drug. It can be used in people over the age of 12 weighing 88 pounds or more. It can help speed up the recovery time for people with COVID-19.
- Baricitinib in combination with remdesivir is available for use in patients over the age of 2 who need respiratory support.
- Blood thinners in low doses are frequently used to prevent blood clots. Many people with COVID-19 develop them. Doctors may prescribe higher doses of blood thinners in people who are at high risk for developing blood clots
Scientists continue to study COVID-19. They update guidance on treatments as new evidenced-based research becomes available.
The following information is courtesy of Combat Covid
You May Like: What Is The Survival Rate Of Covid-19
What Are The Available Covid
If you or a loved one test positive for COVID-19, you may now have treatment options. COVID-19 treatment options are available for patients with mild to moderate symptoms and for hospitalized patients. Mild symptoms may include fever, cough, sore throat, malaise , headache, muscle pain, nausea, vomiting, diarrhea, and loss of taste and smell. Moderate symptoms may also include shortness of breath.
The U.S. Food and Drug Administration has authorized treatments for emergency use. See Combat Covid for more in depth information on Covid-19 treatment options.
Are You High Risk For Severe Covid
The criteria for patients to be considered for Monoclonal Antibody infusion therapy are:
- Test positive for SARS-CoV-2
- Have at least mild symptoms for no more than seven days
- Are age 65 plus or less than 65 but have a chronic health problem that puts you at risk for severe COVID-19. These include obesity, diabetes, lung disease, and heart disease, among others.
Monoclonal antibody therapy needs to be given as soon as possible after symptoms start to workideally within 4 days and no longer than seven days.
To find out if you are at high risk and eligible for COVID 19 Monoclonal Antibody infusion therapy, please call the UNC COVID Help Line at 888-850-2684, between 8 a.m. and 5 p.m., 7 days a week.
Providers outside of UNC Health can also call the Help Line for information about whether patients meet detailed criteria and can be referred to a UNC Health clinic for monoclonal antibody treatment. UNC Health providers should check the intranet resources for treatment criteria and referral information.
You May Like: How To Tell A Cold From Covid
New Criteria Mean More People Qualify For Therapy
In May, the FDA expanded the criteria for who can receive it, dropping the qualifying age from 55 to 12, which gave more discretion to the doctors who would be writing the prescriptions. The changes also included new weight guidelines that allow some 75% of Texans to qualify to receive it; the majority of Texans are overweight, which increases the risk of hospitalization for COVID patients.
Regeneron is most effective on people with COVID-19 who have had symptoms for less than 10 days, but the FDAs broad guidelines largely leave the decision of who should receive it up to physicians, health officials say.
In an email to staff at Houston Methodist hospital system on Wednesday, Dr. Robert A. Phillips, executive vice president and chief physician executive, said the hospital has scheduled 867 infusions for this week more than double the highest number for a single week during the last surge.
The Texas Department of State Health Services sent Houston Methodist 17 nurses to help administer the treatment, he said in the email. They arrived last week.
As you may know, Gov. Abbott is receiving monoclonal antibody treatment after testing positive for COVID-19. This likely will bring more attention to this treatment, which has proven to cut down on hospitalizations, he wrote.
Nim Kidd, chief of the Texas Division of Emergency Management, said hes glad to see the enthusiasm.
Monoclonal Antibody Therapy Covid
Johns Hopkins Medicine is providing outpatient infusion therapy in Maryland;for patients with COVID-19.
Johns Hopkins Medicine and the University of Maryland Medical System are operating an outpatient center located at the Baltimore Convention Center. The infusion center;administers monoclonal antibody therapies authorized by the U.S. Food and Drug Administration under an emergency use authorization . Referrals are required. Monoclonal antibody therapy helps prevent hospitalization or worsening of symptoms in certain patients with COVID-19, but it may not be appropriate for everyone.
Therapy consists of treatment with combination of casirivimab and imdevimab, administered simultaneously
Don’t Miss: Did Hank Aaron Get Covid Vaccine
Who Is Eligible For Monoclonal Antibody Treatment
Anyone who tested positive for COVID-19, has had symptoms for 10 days or less, and one of the following:
- Be at least 65 years old
- Have a BMI of more than 25 kg/m2, or if age 12-17, have BMI above the 85th percentile for their age and gender based on CDC growth charts
- Currently Pregnant
- Have a medical condition, including:
- Chronic kidney disease
- Cardiovascular disease